INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly and Co. said it will cut prices of its most commonly prescribed insulins up to 70% and expand a program that limits ...

Insulin isophane suspension (NPH) (human, rDNA origin) 100 Units/mL; inj. Instruct patients on proper administration of insulin, check insulin label before each injection, and management of ...

INDIANAPOLIS — Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on the costs they pay to fill prescriptions. The moves announced ...

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise critical ...

HARRISBURG, Pa. — Eli Lilly, one of the nation’s biggest manufacturers of insulin, announced it will reduce the list price of some of its insulins and cap out-of-pocket insulin costs to $35 a month.

More Americans with diabetes will get a break on their insulin costs in 2024. Sanofi is joining the nation's two other major insulin manufacturers in offering either price caps or savings programs ...

Eli Lilly and Co. said it will cut prices of its most commonly prescribed insulins up to 70% and expand a program that limits out-of-pocket monthly costs for some consumers. The Indianapolis drugmaker ...